Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Gross Margin (2024 - 2025)

Historic Gross Margin for Autolus Therapeutics (AUTL) over the last 2 years, with Q3 2025 value amounting to 35.15%.

  • Autolus Therapeutics' Gross Margin changed N/A to 35.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 61.21%, marking a year-over-year change of. This contributed to the annual value of 12.52% for FY2024, which is 1125200.0% down from last year.
  • According to the latest figures from Q3 2025, Autolus Therapeutics' Gross Margin is 35.15%.
  • Autolus Therapeutics' 5-year Gross Margin high stood at 100.0% for Q1 2024, and its period low was 39165.52% during Q4 2024.